PH12014502836B1 - Medicament form for release of active ingredients - Google Patents
Medicament form for release of active ingredientsInfo
- Publication number
- PH12014502836B1 PH12014502836B1 PH12014502836A PH12014502836A PH12014502836B1 PH 12014502836 B1 PH12014502836 B1 PH 12014502836B1 PH 12014502836 A PH12014502836 A PH 12014502836A PH 12014502836 A PH12014502836 A PH 12014502836A PH 12014502836 B1 PH12014502836 B1 PH 12014502836B1
- Authority
- PH
- Philippines
- Prior art keywords
- medicament
- core
- active ingredient
- medicament form
- release
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
This invention is concerned with the provision of medicament forms which enable effective administration of a medicament which is usually taken twice or more daily by way of a single daily dose. This is achieved in accordance with the invention by provision of a medicament form comprising a core, a gastric juice-resistant intermediate layer disposed on the surface of the core, and a shell disposed on the opposite side of the intermediate layer from the core. Both the core and the shell comprise a proportion of an active ingredient. The active ingredient is released in at least biphasic form from the medicament form, the first phase relating to the immediate release of the active ingredient after ingestion into the gastric juice. The present invention additionally relates to a process for producing the medicament form and to uses thereof.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102012105528.9A DE102012105528A1 (en) | 2012-06-25 | 2012-06-25 | Pharmaceutical form for the release of active substances |
PCT/EP2013/063162 WO2014001267A2 (en) | 2012-06-25 | 2013-06-24 | Medicament form for release of active ingredients |
Publications (2)
Publication Number | Publication Date |
---|---|
PH12014502836B1 true PH12014502836B1 (en) | 2015-02-02 |
PH12014502836A1 PH12014502836A1 (en) | 2015-02-02 |
Family
ID=48656002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH12014502836A PH12014502836A1 (en) | 2012-06-25 | 2014-12-19 | Medicament form for release of active ingredients |
Country Status (20)
Country | Link |
---|---|
EP (2) | EP2679216B1 (en) |
AU (1) | AU2013283473B2 (en) |
BR (1) | BR112014032578B1 (en) |
CA (1) | CA2877190C (en) |
CO (1) | CO7250447A2 (en) |
DE (1) | DE102012105528A1 (en) |
DK (1) | DK2679216T3 (en) |
EA (1) | EA030871B1 (en) |
ES (2) | ES2607447T3 (en) |
HU (2) | HUE031246T2 (en) |
IL (1) | IL236466B (en) |
IN (1) | IN2014MN02526A (en) |
MX (1) | MX367284B (en) |
MY (1) | MY168531A (en) |
PH (1) | PH12014502836A1 (en) |
PL (2) | PL2863896T3 (en) |
PT (2) | PT2679216E (en) |
UA (1) | UA118836C2 (en) |
WO (1) | WO2014001267A2 (en) |
ZA (1) | ZA201409506B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2936748C (en) | 2014-10-31 | 2017-08-08 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
ES2862209T3 (en) | 2017-07-20 | 2021-10-07 | Intas Pharmaceuticals Ltd | Solid non-pulsatile prolonged-release oral compositions containing betahistine |
US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
DE102018129419A1 (en) | 2018-11-22 | 2020-05-28 | Johannes Gutenberg-Universität Mainz | Acrylate copolymer for pharmaceutical applications |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4503031A (en) * | 1982-12-17 | 1985-03-05 | Glassman Jacob A | Super-fast-starting-sustained release tablet |
IT1229237B (en) * | 1989-05-08 | 1991-07-26 | Prodotti Formenti | SALTS OF (2- (PYRIDYL) ETHYL) METHYLAMINE |
ES2051658T3 (en) * | 1992-08-06 | 1998-06-16 | Gergely Gerhard | EFFERVESCENT TABLETS EASY TO MANAGE. |
HRP970493A2 (en) | 1996-09-23 | 1998-08-31 | Wienman E. Phlips | Oral delayed immediate release medical formulation and method for preparing the same |
US6419960B1 (en) * | 1998-12-17 | 2002-07-16 | Euro-Celtique S.A. | Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations |
IT1309591B1 (en) | 1999-03-05 | 2002-01-24 | Formenti Farmaceutici Spa | COMPOSITIONS WITH BETAISTINE CONTROLLED RELEASE. |
DE10010509A1 (en) | 2000-03-08 | 2001-09-13 | Dresden Arzneimittel | Oral pharmaceutical formulations with controllable release characteristics, e.g. rapid or delayed release, contain sucrose fatty acid ester as drug release controlling agent |
DE10104880A1 (en) | 2001-01-31 | 2002-08-08 | Roehm Gmbh | Multiparticulate pharmaceutical form, containing at least two differently coated pellet forms |
SI1493435T1 (en) * | 2003-07-04 | 2008-10-31 | Formenti Farmaceutici Spa | Controlled Release Compositions of Betahistine |
US20060280795A1 (en) * | 2005-06-08 | 2006-12-14 | Dexcel Pharma Technologies, Ltd. | Specific time-delayed burst profile delivery system |
ES2400964T3 (en) * | 2007-04-04 | 2013-04-15 | Sigmoid Pharma Limited | Pharmaceutical compositions of cyclosporine |
WO2012110912A1 (en) * | 2011-02-17 | 2012-08-23 | Lupin Limited | Sustained release composition of memantine |
-
2012
- 2012-06-25 DE DE102012105528.9A patent/DE102012105528A1/en not_active Ceased
-
2013
- 2013-06-24 HU HUE13730597A patent/HUE031246T2/en unknown
- 2013-06-24 DK DK13173438.6T patent/DK2679216T3/en active
- 2013-06-24 BR BR112014032578-2A patent/BR112014032578B1/en active IP Right Grant
- 2013-06-24 UA UAA201500502A patent/UA118836C2/en unknown
- 2013-06-24 IN IN2526MUN2014 patent/IN2014MN02526A/en unknown
- 2013-06-24 EP EP13173438.6A patent/EP2679216B1/en active Active
- 2013-06-24 EA EA201500044A patent/EA030871B1/en unknown
- 2013-06-24 HU HUE13173438A patent/HUE025739T2/en unknown
- 2013-06-24 ES ES13730597.5T patent/ES2607447T3/en active Active
- 2013-06-24 PT PT131734386T patent/PT2679216E/en unknown
- 2013-06-24 AU AU2013283473A patent/AU2013283473B2/en active Active
- 2013-06-24 MX MX2014015660A patent/MX367284B/en active IP Right Grant
- 2013-06-24 ES ES13173438.6T patent/ES2546172T3/en active Active
- 2013-06-24 WO PCT/EP2013/063162 patent/WO2014001267A2/en active Application Filing
- 2013-06-24 CA CA2877190A patent/CA2877190C/en active Active
- 2013-06-24 PT PT137305975T patent/PT2863896T/en unknown
- 2013-06-24 MY MYPI2014003551A patent/MY168531A/en unknown
- 2013-06-24 EP EP13730597.5A patent/EP2863896B1/en active Active
- 2013-06-24 PL PL13730597T patent/PL2863896T3/en unknown
- 2013-06-24 PL PL13173438T patent/PL2679216T3/en unknown
-
2014
- 2014-12-19 PH PH12014502836A patent/PH12014502836A1/en unknown
- 2014-12-23 ZA ZA2014/09506A patent/ZA201409506B/en unknown
- 2014-12-25 IL IL236466A patent/IL236466B/en active IP Right Grant
-
2015
- 2015-01-15 CO CO15007542A patent/CO7250447A2/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2019007956A (en) | Self-regulated release of active pharmaceutical ingredient. | |
WO2012131463A3 (en) | Controlled release pharmaceutical dosage forms | |
IN2014DN10548A (en) | ||
WO2011107755A3 (en) | Immediate/delayed drug delivery | |
WO2011076749A3 (en) | Solid pharmaceutical dosage form of ticagrelor | |
TN2012000566A1 (en) | Dry powder formulation comprising an antimuscarinic drug | |
CL2014002935A1 (en) | Method to treat a human patient with multiple sclerosis with laquinimod, at a daily dose of about 1.2mg; an oral unit dosage form of 1.2 mg of laquinimod and a carrier | |
WO2011159100A2 (en) | Anti-cancer pharmaceutical composition | |
MY165888A (en) | Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation | |
PH12020550806A1 (en) | Core tablet composite preparation comprising mosapride and rabeprazole | |
PH12014501408A1 (en) | Immediate release multi unit pellet system | |
PH12015500653B1 (en) | Combination drug comprising gemigliptin and metformin, and method for the preparation thereof | |
PH12014502836A1 (en) | Medicament form for release of active ingredients | |
MX2017013636A (en) | Tamper-resistant fixed dose combination providing fast release of two drugs from different particles. | |
MD4563C1 (en) | Co-micronisation product comprising ulipristal acetate | |
UA108277C2 (en) | Complex preparation containing lercanidipine hydrochloride and valsartan, and method for production | |
GR1008228B (en) | Pharmaceutical composition comprising a dual reuptake inhibitor and method for the preparation thereof | |
MX2017013633A (en) | Tamper-resistant fixed dose combination providing fast release of two drugs from particles. | |
NZ613264A (en) | Use of vitamin k for weight maintenance and weight control | |
MX2017013643A (en) | Tamper-resistant fixed dose combination providing fast release of two drugs from particles and a matrix. | |
JP2013079218A5 (en) | ||
IN2012CH05549A (en) | ||
WO2012033348A3 (en) | Composition for the prevention or treatment of allergic diseases comprising 2-linoleoyl glycerol | |
TN2013000212A1 (en) | Complex formulation comprising lercanidipine hydrochloride and valsartan and mathod for the preparation therof | |
WO2011107922A3 (en) | Extended release composition of milnacipran |